Medical University of South Carolina
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).
Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.
Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.
Top-decile sponsor footprint
Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
755 total, page 2 of 16
Accelerated TMS for Seizure-Type Functional Neurologic Disorders
NCT07059325
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
NCT06157840
Clinical Alternatives for Reducing Harm Using E-cigarettes
NCT07039292
Cognitive Decline Following Deep Brain Stimulation: A DBS-fMRI Study
NCT06960096
Optimizing Care for Cancer Survivors With Depression: Project 3
NCT06930729
Accelerated rTMS vs. Sham for Stroke Apathy
NCT07113067
Physical Capacity Building for Chronic Stroke
NCT07039305
A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome
NCT06676488
Improving Behavioral Health for Caregivers and Children After Pediatric Injury
NCT06856057
MEP Up-conditioning to Target Corticospinal Plasticity
NCT06989905
Establishing Mobile Transcranial Magnetic Stimulation
NCT06748209
Cannabis-Tobacco Co-Use Treatment Study
NCT06883162
Phase 2 Study of Fingolimod in Lung Cancers
NCT06424067
Emotional Recovery Post-Stroke
NCT06782321
Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma
NCT06905132
Randomized Trial of Tele Vs. Clinic TF-CBT in Puerto Rico
NCT06332209
Correlation of STN-DBS Induced Visuospatial Changes and Freezing of Gait
NCT06994728
Integrated Treatment for Opioid Use Disorder and PTSD
NCT06641115
E-cigarette Cessation in Adults Who Co-use Cannabis
NCT06688539
Evaluation of Low and High Nicotine Tobacco Free Nicotine Pouches
NCT06678789
Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People
NCT05816083
Weekly Isotretinoin vs Tetracycline for Moderate Acne
NCT06225570
StrokeNet Thrombectomy Endovascular Platform
NCT06289985
HVIP Outcomes and Stakeholder Insights
NCT06582953
Efficacy of Intramuscular Steroid Injection for Chronic Cough.
NCT06634823
Accelerated TMS for Freezing of Gait in Parkinson's Disease
NCT06982638
Imaging Biomarkers of FOG Response to DBS
NCT06951906
Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke Walking
NCT07050355
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
NCT06582784
At-Home taVNS - Stroke Rehab
NCT06616831
A Brief Intervention for Cannabis Use
NCT06395389
Citicoline in Youth Alcohol Use Disorder
NCT05870111
fMRI Accelerated TMS Depression
NCT06562153
ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain
NCT06442566
Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain
NCT06205342
Switch or Quit R01
NCT06373679
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
NCT06451003
QL vs LAI for Palatoplasty
NCT06420336
tFUS Induced Transient Scotoma for Individual Dosing
NCT06426498
Transcranial Magnetic Stimulation for MCI
NCT05992831
Healing, Equity, Advocacy and Respect for Mamas
NCT06273436
Modulating Escape Using Focused Ultrasound
NCT06273904
Young Adult Tobacco/Nicotine and Cannabis Co-use
NCT06239350
Induction in the Dark
NCT06144177
taVNS for Anxiety in ASD
NCT06258590
SMYLS Multi-site Trial
NCT06035939
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
NCT06118502
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
NCT05586360
Advancing Couple and Family Alcohol Treatment Through Patient-Oriented Research and Mentorship
NCT05786157
MITIGAAT: Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants
NCT06023615
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 104 |
| Phase 2 | 124 |
| Phase 3 | 23 |
| Phase 4 | 43 |
Therapeutic Areas
What is open in the Medical University of South Carolina pipeline
142 recruiting of 755 indexed (19% open); 520 completed (69%).
Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Stroke (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical University of South Carolina: open-pipeline peers nationwide
Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 755 trials (± recruiting share)
- University of California, San Diego · 775 trials · 18% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Spaulding Rehabilitation Hospital · 19% recruiting · 101 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Medical University of South Carolina page
755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.
- 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medical University of South Carolina pipeline card: 755 registered trials from official public datasets.Report a data error.